HHHBIO
Live / Registered — Registered (as of 29 Jun 2021)
What this means for you
Registered since 29 Jun 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79300811
- Registration number
- 6399124
- Mark type
- Word mark
- Filed
- 10 Jul 2020
- Published for opposition
- 13 Apr 2021
- Registered
- 29 Jun 2021
- Attorney of record
- Paul G. Johnson
Goods and services
- Class 005 — Pharmaceuticals: Drugs for medical purposes, namely, drugs for the treatment of oncological and metabolic diseases and disorders; medicines for human purposes, namely, medicine for the treatment of infectious diseases; medicines for human purposes, namely, medicine for the treatment of viral diseases and disorders; medicines for human purposes, namely, medicine for the treatment of respiratory diseases and disorders; therapeutic drugs and agents, namely, therapeutic drugs for the treatment of immune system related diseases and disorders; pharmaceutical preparations for preventing and treating obesity; vaccines; human vaccine preparations; pharmaceutical agents affecting metabolism; protein for medical purposes, namely, protein arrays for diagnosing cancer; protein for medical purposes, namely, protein arrays for diagnosing allergies; peptide for medical purposes, namely, synthetic peptides for the treatment of immune system related diseases and disorders; synthetic protein for the treatment of diabetes; synthetic protein for the treatment of oncological and metabolic diseases and disorders; synthetic peptide for the treatment of obesity; synthetic peptide for the treatment of viral diseases and disorders; pharmaceutical preparations containing peptides as the active ingredients, namely, pharmaceutical preparations for the treatment of neurological diseases and disorders
- Class 042 — Scientific and technological services: Research relating to pharmaceuticals, namely, pharmaceutical research services; medicine research, namely, research and development of medicines; medical analysis services of peptide for the treatment of people; research for medical products, namely medical research; chemical research; biological research; laboratory research in the field of pharmaceuticals; clinical studies of medicines, namely, conducting clinical trials for others; operation of medical laboratory, namely, medical laboratory services; scientific research for medical purposes; research and development of peptide for medical purposes; research of biology; research and development of peptide for scientific or laboratory purposes; drug discovery services; research and development of technology for biotechnology; development of pharmaceutical preparations and medicines
Owner
- 3H Bio. Co., Ltd., KR
- 3H Bio. Co., Ltd., KR
- 3H Bio. Co., Ltd., KR
Prosecution history
- 28 Jan 2022 — NEW REPRESENTATIVE AT IB RECEIVED
- 23 Nov 2021 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 28 Oct 2021 — FINAL DISPOSITION NOTICE SENT TO IB
- 28 Oct 2021 — FINAL DISPOSITION PROCESSED
- 29 Sept 2021 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 29 Jun 2021 — REGISTERED-PRINCIPAL REGISTER
- 13 Apr 2021 — NOTIFICATION PROCESSED BY IB
- 13 Apr 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Apr 2021 — PUBLISHED FOR OPPOSITION
- 24 Mar 2021 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 24 Mar 2021 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 24 Mar 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Mar 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Mar 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Mar 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE